Hyaluronic acid suture line and preparation method thereof

Through multiple dialysis and double modification crosslinking technology, combined with ε-polylysine hydrochloride to form an inner gel, the problem of damage to wounds and anti-allergic crosslinking agents of hyaluronic acid sutures during removal is solved, and the problem of anti-allergic crosslinking agents is achieved. It has efficient healing and antibacterial effects, and the sutures can completely absorb and metabolize.

CN119055819APending Publication Date: 2024-12-03BEIJING JIMANO MEDICAL TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411179568.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing hyaluronic acid sutures can cause additional damage to the wound during removal surgery and daily management, increasing the risk of bacterial penetration and infection, and the high content of crosslinking agents will lead to anti-allergic reactions in the human body, making the maintenance time difficult to regulate.

Method used

Multiple dialysis removal crosslinking agent technology is used to form a double modified crosslinked modified hyaluronic acid by coupling methacrylate with primary alcohol of hyaluronic acid and sodium periodate modification, combining ε-polylysine salt The acid salt forms an inner gel, improves mechanical strength and adhesion properties, and prepares hyaluronic acid sutures through spinning technology.

Benefits of technology

It significantly reduces the residual amount of crosslinking agent and allergic reactions in the human body. The sutures can be completely absorbed and metabolized, improve healing efficiency and antibacterial ability, enhance hemostasis performance and tolerance to dynamic stimulation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005011706490000091
    Figure BDA0005011706490000091
  • Figure BDA0005011706490000111
    Figure BDA0005011706490000111
Patent Text Reader

Abstract

The invention discloses a preparation method of a hyaluronic acid suture line, and relates to the technical field of biomedical materials. The preparation method comprises the following steps: preparing modified hyaluronic acid subjected to double chemical modification, stirring the modified hyaluronic acid under a water bath heating condition, adding a NaOH solution and a cross-linking agent, stirring, cooling, standing, dialyzing and filtering to obtain spinning external gel; adding epsilon-polylysine hydrochloride into the sodium hyaluronate solution, and carrying out ultrasonic treatment and homogenization under a water bath heating condition of 80 DEG C to obtain an inner gel crude product; respectively filling the spinning outer gel and the spinning inner gel into different injectors, respectively connecting the injectors with inner and outer container openings of a coaxial nozzle, setting process parameters for spinning, and refrigerating for later use after vacuum drying to obtain the hyaluronic acid suture line. The residual amount of the cross-linking agent is low, allergy and adverse reactions of a human body can be effectively relieved, stitches do not need to be removed, the cross-linking agent can be completely absorbed and metabolized by the human body, the cross-linking agent has good mechanical strength, and the cross-linking agent is further degraded to provide adhesion, water absorption, antibacterial and hemostatic functions and nutrient substances.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biomedical materials, in particular to a hyaluronic acid suture and a preparation method thereof. Background Art

[0002] Sodium hyaluronate is an inherent component of the human body and an anionic glycosaminoglycan. It is widely present in tissues such as the placenta, amniotic fluid, lens, articular cartilage, and skin dermis. It has good hydrophilicity, water retention, biocompatibility, and non-immunogenicity. It has been widely used in plastic surgery, tissue engineering, osteoarthritis relief, and lubrication.

[0003] Sutures are the primary means of stopping bleeding, fluid loss, and achieving wound closure following traumatic lacerations and surgical incisions, but despite their high tensile strength, they can cause additional trauma to the wound due to wear and tear from surgical removal and daily management, and increase the risk of bacterial penetration and subsequent infection. The use of absorbable sutures in wound closure and healing shows great promise, with minimally invasive applications, the ability to enhance wound repair, and the protective seal formed on the wound.

[0004] When using sodium hyaluronate to support gel, in order to maintain the absorption time in the body, a cross-linking agent is required for cross-linking. The higher the degree of cross-linking, the longer the maintenance time, while the lower the degree of cross-linking, the shorter the maintenance time. The shortest is the non-cross-linked gel. However, when the cross-linking is too high, the human body will be allergic to the cross-linking agent. If the content of the cross-linking agent is reduced, the maintenance time cannot be guaranteed. Summary of the invention

[0005] The object of the present invention is to provide a hyaluronic acid suture and a preparation method thereof to solve the problems raised in the background technology.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] A method for preparing a hyaluronic acid suture comprises the following steps:

[0008] S1. Dissolve hyaluronic acid in deionized water at 4°C, add N,N-dimethylformamide, adjust the pH of the reaction solution to 8-9 with 2% NaOH by mass, add methacrylic anhydride dropwise, maintain the pH value at 8-9 and stand for 12-14 hours, adjust the pH to 6-7 with 0.5% HCl at 25°C, add sodium periodate, stir in dark for 12-14 hours, dialyze with deionized water for 3 days, change the water 4 times a day, quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid;

[0009] It should be noted that the methacrylate moiety is coupled to the primary alcohol on the hyaluronic acid through methacrylic anhydride. Due to the poor solubility of methacrylic anhydride under aqueous conditions, N,N-dimethylformamide is used as a cosolvent for the reaction. The methacrylate vinyl protons coupled to the hyaluronic acid backbone can greatly increase the elastic modulus and mechanical strength of the hyaluronic acid gel. Sodium periodate is added to the reaction solution to cause the hyaluronic acid to undergo a ring-opening oxidation reaction. The oxidation of the diol on the glucuronic acid in the hyaluronic acid backbone will obtain aldehyde-modified hyaluronic acid. The aldehyde functional group allows cross-linking with other modified biopolymers or cross-linking agents, and is also a site for adhesion to natural proteins and collagen on the tissue surface. The adhesion function also helps to retain the hydrogel at the wound site to achieve more effective healing and more sustained release of therapeutic drugs. Methacrylate and aldehyde-modified hyaluronic acid constitute a double-modified cross-linked modified hyaluronic acid, which improves the mechanical strength and adhesion properties of hyaluronic acid.

[0010] S2, stirring the modified hyaluronic acid in a water bath at 50-55° C. for 3-5 min, adding 1% by mass NaOH solution and 1,4-butanediol diglycidyl ether, stirring for 2-3 h, cooling to 25° C., and standing for 48 h to obtain a crude exogel;

[0011] S3, dialyzing the crude outer gel, filtering through a polycarbonate membrane with decreasing pore size three times to obtain a spinning outer gel;

[0012] S4, adding ε-polylysine hydrochloride to the sodium hyaluronate solution, ultrasonically homogenizing under heating conditions at 80° C. in a water bath for 30-60 minutes to obtain a crude inner gel;

[0013] It should be noted that the degradation product of ε-polylysine hydrochloride (ε-PLL) is lysine, which is an essential amino acid for the human body. ε-PLL itself has broad-spectrum antibacterial activity and has been used as an antibacterial agent and food preservative. ε-PLL collides and aggregates with hyaluronic acid (HA) to form white or translucent floccules visible to the naked eye and precipitates from the solution. A large number of ε-PLL cations are distributed around the HA anions with longer molecular chains. The dilution of the water environment reduces the ionic strength, electrostatic repulsion and stability of the system. External forces promote further collisions between colloidal particles, leading to the occurrence of coagulation. At the same time, due to the strong electrostatic interaction between the two polyelectrolytes of ε-PLL and HA, initial coagulation occurs between the two to form a uniform viscous solution. The condensed inner gel crude has a strong ability to remove interfacial water in wet tissues. This is because both polyelectrolytes are highly hydrophilic and have strong water absorption and drainage capabilities under the promotion of continuous water channels. The crude inner gel can maintain viscosity and exhibit shear-thinning properties through the synergistic effects of multiple intermolecular interactions, including hydrogen bonds, electrostatic interactions, and van der Waals forces, etc., which can improve the adhesion strength to wet tissue under various pressures and other physiological environmental conditions, and enhance the hemostatic performance and tolerance to dynamic stimulation. It has excellent biocompatibility and antibacterial ability. As the internal structure of hyaluronic acid sutures, it further degrades after the external degradation of the sutures to provide adhesion, water absorption, antibacterial, hemostatic functions and essential amino acids for the human body.

[0014] S5. The outer spinning gel and the inner spinning gel are loaded into different syringes respectively, and the inner and outer container ports of the coaxial nozzle are connected respectively. After setting the process parameters, spinning is started. After vacuum drying, the gel is refrigerated for later use, and the hyaluronic acid suture is obtained.

[0015] Furthermore, the molecular weight of the hyaluronic acid described in S1 is 100-500 kDa.

[0016] Furthermore, the dosage ratio of hyaluronic acid, deionized water, N,N-dimethylformamide, methacrylic anhydride and sodium periodate in S1 is 1 g:50 mL:50 mL:(1.02-1.3) mL:0.53 g.

[0017] Furthermore, in S2, the usage ratio of the modified hyaluronic acid, the 1% NaOH solution by mass, and 1,4-butanediol diglycidyl ether is 25 g:110 g:(0.3-0.5) mg.

[0018] Furthermore, the dialysis operation in S3 is: dialysis with normal saline for 20 times, and finally dialysis with 5% glucose normal saline buffer for 3 times.

[0019] It should be noted that the present invention adopts multiple dialysis cross-linking agent removal technology to remove excess and most of the cross-linking agent until the residual amount of the cross-linking agent 1,4-butanediol diglycidyl ether in the outer gel is detected to be less than 2ug / mL, which can effectively reduce human allergies and adverse reactions.

[0020] Furthermore, the polycarbonate membranes with reduced pore size described in S3 are 2 μm membranes, 1.5 μm membranes, and 1 μm membranes, respectively.

[0021] Furthermore, the final concentration of sodium hyaluronate in the crude inner gel of S4 is 50-80 mg / mL, and the final concentration of ε-polylysine salt is 500-650 mg / mL.

[0022] Furthermore, the usage ratio of the spinning outer gel and the spinning inner gel in S5 is (1-1.08):1.

[0023] Furthermore, the process parameters of S5 are: working voltage 15-25 kV, the distance between the fixed needle collector and the high-speed orientation receiver is 15 cm, the fixed speed of the high-speed orientation receiver is 200-300 r / min, the flow rate is 1.94 mL / h, and the spinning time is 8-20 min.

[0024] A hyaluronic acid suture prepared by the preparation method mentioned above.

[0025] Compared with the prior art, the present invention has the following beneficial effects:

[0026] The hyaluronic acid suture prepared by the present invention adopts multiple dialysis cross-linking agent removal technology to remove excess cross-linking agent, so that the residual amount of cross-linking agent is less than 2ug / mL, which meets the national standard, can effectively reduce human allergies and adverse reactions, does not need to be removed after suturing, and can be completely absorbed and metabolized by the human body.

[0027] The external structure of the hyaluronic acid suture prepared by the present invention is a modified hyaluronic acid that is double-modified and cross-linked with methacrylate and aldehyde, which can greatly increase the elastic modulus and mechanical strength of the hyaluronic acid gel, and can adhere to the natural protein and collagen on the tissue surface, thereby achieving more effective healing and more lasting release of therapeutic drugs.

[0028] The internal structure of the hyaluronic acid suture prepared by the present invention is a flocculent formed by the collision and aggregation of ε-polylysine hydrochloride and hyaluronic acid, which has a strong ability to remove interfacial water in wet tissue and antibacterial ability, improves the adhesion strength to wet tissue, enhances hemostatic performance and tolerance to dynamic stimulation, and further degrades after the external structure of the suture is degraded to provide essential nutrients for the human body. DETAILED DESCRIPTION

[0029] The following will be described clearly and completely in conjunction with the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] Example 1

[0031] S1. Dissolve 1.00 g of hyaluronic acid (molecular weight 120 kDa) in 50 mL of deionized water at 4°C, add 50 mL of N,N-dimethylformamide, adjust the pH of the reaction solution to 8.5 with 2% NaOH by mass, and simultaneously add 1.30 mL of methacrylic anhydride dropwise, maintain the pH value at 8.5 and stand for 12 h, adjust the pH to 6.5 with 0.5% HCl at 25°C, add 0.53 g of sodium periodate, stir for 12 h in the dark, dialyze with deionized water for 3 days, change the water 4 times a day, and quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid;

[0032] S2, stirring 25 g of modified hyaluronic acid in a 50° C. water bath for 3 min, adding 110 g of 1% NaOH solution and 0.5 mg of 1,4-butanediol diglycidyl ether, stirring for 3 h, cooling to 25° C., and standing for 48 h to obtain a crude outer gel;

[0033] S3, dialyzing the crude outer gel 20 times with normal saline, and finally dialyzing 3 times with 5% glucose normal saline buffer, filtering through 2 μm, 1.5 μm and 1 μm polycarbonate membranes 3 times respectively, to obtain the spinning outer gel;

[0034] S4. Add ε-polylysine hydrochloride to the sodium hyaluronate solution, perform ultrasonication in a water bath at 80°C, and homogenize for 45 minutes to obtain a crude inner gel having a final sodium hyaluronate concentration of 60 mg / mL and a final ε-polylysine hydrochloride concentration of 550 mg / mL.

[0035] S5. Load the outer spinning gel and the inner spinning gel into different syringes respectively, and connect the inner and outer container ports of the coaxial nozzle respectively, set the process parameters: working voltage 20 kV, the distance between the fixed needle collector and the high-speed orientation receiver is 15 cm, the fixed speed of the high-speed orientation receiver is 250 r / min, the flow rate is 1.94 mL / h, spinning for 12 min, vacuum drying and refrigeration for later use, to obtain hyaluronic acid sutures.

[0036] Example 2

[0037] S1. Dissolve 1.00 g of hyaluronic acid in 50 mL of deionized water at 4°C, add 50 mL of N,N-dimethylformamide, adjust the pH of the reaction solution to 8.5 with 2% NaOH, and simultaneously add 1.02 mL of methacrylic anhydride dropwise, maintain the pH value at 8.5 and stand for 12 h, adjust the pH to 6.5 with 0.5% HCl at 25°C, add 0.53 g of sodium periodate, stir for 12 h in the dark, dialyze with deionized water for 3 days, change the water 4 times a day, and quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid;

[0038] S2, stirring 25 g of modified hyaluronic acid in a 50° C. water bath for 3 min, adding 110 g of 1% NaOH solution and 0.5 mg of 1,4-butanediol diglycidyl ether, stirring for 3 h, cooling to 25° C., and standing for 48 h to obtain a crude outer gel;

[0039] S3, dialyzing the crude outer gel 20 times with normal saline, and finally dialyzing 3 times with 5% glucose normal saline buffer, filtering through 2 μm, 1.5 μm and 1 μm polycarbonate membranes 3 times respectively, to obtain the spinning outer gel;

[0040] S4. Add ε-polylysine hydrochloride to the sodium hyaluronate solution, perform ultrasonication in a water bath at 80°C, and homogenize for 45 minutes to obtain a crude inner gel having a final sodium hyaluronate concentration of 50 mg / mL and a final ε-polylysine hydrochloride concentration of 600 mg / mL.

[0041] S5. Load the outer spinning gel and the inner spinning gel into different syringes respectively, and connect the inner and outer container ports of the coaxial nozzle respectively, set the process parameters: working voltage 20 kV, the distance between the fixed needle collector and the high-speed orientation receiver is 15 cm, the fixed speed of the high-speed orientation receiver is 250 r / min, the flow rate is 1.94 mL / h, spinning for 12 min, vacuum drying and refrigeration for later use, to obtain hyaluronic acid sutures.

[0042] Example 3

[0043] S1. Dissolve 1.00 g of hyaluronic acid in 50 mL of deionized water at 4°C, add 50 mL of N,N-dimethylformamide, adjust the pH of the reaction solution to 8.5 with 2% NaOH, and drop 1.16 mL of methacrylic anhydride at the same time, maintain the pH value at 8.5 and stand for 12 hours, adjust the pH to 6.5 with 0.5% HCl at 25°C, add 0.53 g of sodium periodate, stir for 12 hours in the dark, dialyze with deionized water for 3 days, change the water 4 times a day, and quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid;

[0044] S2, stirring 25 g of modified hyaluronic acid in a 50° C. water bath for 3 min, adding 110 g of 1% NaOH solution and 0.5 mg of 1,4-butanediol diglycidyl ether, stirring for 3 h, cooling to 25° C., and standing for 48 h to obtain a crude outer gel;

[0045] S3, dialyzing the crude outer gel 20 times with normal saline, and finally dialyzing 3 times with 5% glucose normal saline buffer, filtering through 2 μm, 1.5 μm and 1 μm polycarbonate membranes 3 times respectively, to obtain the spinning outer gel;

[0046] S4. Add ε-polylysine hydrochloride to the sodium hyaluronate solution, perform ultrasonication in a water bath at 80°C, and homogenize for 45 minutes to obtain a crude inner gel having a final sodium hyaluronate concentration of 70 mg / mL and a final ε-polylysine hydrochloride concentration of 510 mg / mL.

[0047] S5. Load the outer spinning gel and the inner spinning gel into different syringes respectively, and connect the inner and outer container ports of the coaxial nozzle respectively, set the process parameters: working voltage 20 kV, the distance between the fixed needle collector and the high-speed orientation receiver is 15 cm, the fixed speed of the high-speed orientation receiver is 250 r / min, the flow rate is 1.94 mL / h, spinning for 12 min, vacuum drying and refrigeration for later use, to obtain hyaluronic acid sutures.

[0048] Comparative Example 1

[0049] S1. Dissolve 1.00 g of hyaluronic acid in 50 mL of deionized water at 4 °C, add 50 mL of N,N-dimethylformamide, adjust the pH of the reaction solution to 8.5 with 2% NaOH, and simultaneously add 1.30 mL of methacrylic anhydride dropwise, maintain the pH value at 8.5 and stand for 12 h, adjust the pH to 6.5 with 0.5% HCl at 25 °C, add 0.53 g of sodium periodate, stir for 12 h in the dark, dialyze with deionized water for 3 days, change the water 4 times a day, and quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid;

[0050] S2, stirring 25 g of modified hyaluronic acid in a 50° C. water bath for 3 min, adding 110 g of 1% NaOH solution and 0.5 mg of 1,4-butanediol diglycidyl ether, stirring for 3 h, cooling to 25° C., and standing for 48 h to obtain a crude outer gel;

[0051] S3, adding ε-polylysine hydrochloride to the sodium hyaluronate solution, performing ultrasonication under heating conditions at 80° C. in a water bath, and homogenizing for 45 min to obtain a crude inner gel having a final sodium hyaluronate concentration of 60 mg / mL and a final ε-polylysine hydrochloride concentration of 550 mg / mL;

[0052] S4. Load the outer gel crude product and the spinning inner gel into different syringes respectively, and connect the inner and outer container ports of the coaxial nozzle respectively, set the process parameters: working voltage 20kV, fixed needle collector and high-speed orientation receiver distance of 15cm, high-speed orientation receiver fixed speed of 250r / min, flow rate 1.94mL / h, spinning for 12min, vacuum drying and refrigeration for later use, to obtain hyaluronic acid suture.

[0053] The difference between this comparative example and Example 1 is that the step of preparing the spinning outer gel by dialysis filtration of the crude outer gel is omitted.

[0054] Comparative Example 2

[0055] S1. Stir 25 g of hyaluronic acid in a 50° C. water bath for 3 min, add 110 g of 1% NaOH solution and 0.5 mg of 1,4-butanediol diglycidyl ether, stir for 3 h, cool to 25° C., and stand for 48 h to obtain a crude exogel;

[0056] S2, dialyzing the crude outer gel 20 times with normal saline, and finally dialyzing 3 times with 5% glucose normal saline buffer, filtering through a polycarbonate membrane with a 2 μm membrane, a 1.5 μm membrane, and a 1 μm membrane for 3 times, respectively, to obtain a spinning outer gel;

[0057] S3, adding ε-polylysine hydrochloride to the sodium hyaluronate solution, performing ultrasonication under heating conditions at 80° C. in a water bath, and homogenizing for 45 min to obtain a crude inner gel having a final sodium hyaluronate concentration of 60 mg / mL and a final ε-polylysine hydrochloride concentration of 550 mg / mL;

[0058] S4. The outer spinning gel and the inner spinning gel are loaded into different syringes respectively, and connected to the inner and outer container ports of the coaxial nozzle respectively. The process parameters are set as follows: working voltage 20 kV, the distance between the fixed needle collector and the high-speed orientation receiver is 15 cm, the fixed speed of the high-speed orientation receiver is 250 r / min, the flow rate is 1.94 mL / h, spinning for 12 min, vacuum drying and refrigeration for later use, to obtain hyaluronic acid sutures.

[0059] The difference between this comparative example and Example 1 is that unmodified hyaluronic acid is used to prepare the spinning outer gel.

[0060] Comparative Example 3

[0061] S1. Dissolve 1.00 g of hyaluronic acid in 50 mL of deionized water at 4 °C, add 50 mL of N,N-dimethylformamide, adjust the pH of the reaction solution to 8.5 with 2% NaOH, and simultaneously add 1.30 mL of methacrylic anhydride dropwise, maintain the pH value at 8.5 and stand for 12 h, adjust the pH to 6.5 with 0.5% HCl at 25 °C, add 0.53 g of sodium periodate, stir for 12 h in the dark, dialyze with deionized water for 3 days, change the water 4 times a day, and quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid;

[0062] S2, stirring 25 g of modified hyaluronic acid in a 50° C. water bath for 3 min, adding 110 g of 1% NaOH solution and 0.5 mg of 1,4-butanediol diglycidyl ether, stirring for 3 h, cooling to 25° C., and standing for 48 h to obtain a crude gel;

[0063] S3, dialyzing the crude gel 20 times with normal saline, and finally dialyzing 3 times with 5% glucose normal saline buffer, filtering through 2 μm, 1.5 μm and 1 μm polycarbonate membranes 3 times respectively to obtain spinning gel;

[0064] S4. Load the spinning gel into a syringe and connect the inner and outer container ports of the coaxial nozzle respectively, set the process parameters: working voltage 20 kV, fixed needle collector and high-speed orientation receiver distance of 15 cm, high-speed orientation receiver fixed speed of 250 r / min, flow rate 1.94 mL / h, spinning for 12 min, vacuum drying and refrigeration for later use, to obtain hyaluronic acid sutures.

[0065] The difference between this comparative example and Example 1 is that no crude inner gel product is prepared, and the spinning gel is directly used for electrospinning.

[0066] test:

[0067] 1. Mechanical properties

[0068] Environmental parameters: temperature 25°C, humidity 45%, use a stretching machine to uniformly stretch the hyaluronic acid suture at a speed of 50 mm / min until it breaks, and obtain the tensile strength and elongation at break.

[0069] The test results are shown in Table 1.

[0070]

[0071] Table 1

[0072] 2. Biological Toxicity

[0073] Measurement method: Soak the suture sample in DMEM culture medium and culture at 37°C for 2 days to obtain the suture extract. Subsequently, mix the cell extract with the culture medium of fibroblasts and continue to culture at 37°C for 1, 4, and 7 days. Then add a small amount of CCK-8 reagent, culture at 37°C for 1 hour, and finally measure the absorbance at a wavelength of 450nm with an enzyme marker. The control group replaced the extract with pure DMEM culture medium, and other conditions remained unchanged. The higher the absorbance, the more cells there are.

[0074] Cell survival rate (%) = absorbance of experimental group / absorbance of control group × 100%.

[0075] The test results are shown in Table 2.

[0076] Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 Cell survival rate (%) 100.7 100.3 101.5 84.2 99.5 94.0

[0077] Table 2

[0078] 3. Degradation performance

[0079] A PBS buffer solution (pH=7.4) containing 1 mg / mL lysozyme was prepared, and a sufficient amount of the hyaluronic acid suture samples of Examples 1-3 were immersed therein at 37°C. Four fibers were taken each time for mechanical strength measurement. Before the measurement, water droplets on the surface were sucked off with filter paper, and then the mechanical strength was measured with a tensile machine. When there was no more formed suture sample in the solution, it was considered to be completely absorbed, and the time for complete absorption was monitored.

[0080] The test results are shown in Table 3.

[0081] Time for mechanical strength to drop by half 13-15 days Time required for mechanical strength to decrease by 75% 21-24 days When the mechanical strength is completely lost 30-36 days Complete absorption time 58-61 days

[0082] Table 3

[0083] 4. Antibacterial properties

[0084] The antibacterial properties of hyaluronic acid sutures were tested in accordance with the YY 1116-2020 "Absorbable Surgical Sutures" testing methods and standards.

[0085] The test results are shown in Table 4.

[0086]

[0087] Table 4

[0088] V. Conclusion

[0089] 1. As can be seen from Table 1, there is a large gap in the mechanical properties of the hyaluronic acid suture of Comparative Example 2 compared with the mechanical properties of the hyaluronic acid sutures of Examples 1-3, and the mechanical properties of the hyaluronic acid sutures of Comparative Examples 1 and 3 are at the same level as the mechanical properties of the hyaluronic acid sutures of Examples 1-3, with almost no gap, indicating that the spinning exogel prepared by modified hyaluronic acid plays a major role in improving the micromechanical properties in the hyaluronic acid suture of the present invention.

[0090] 2. As can be seen from Table 2, the biological toxicity of the hyaluronic acid suture in Comparative Example 1 is high because there are more cross-linking agent residues; the cell survival rate in Comparative Example 2 is almost the same as that in Examples 1-3, indicating that the spinning outer gel prepared by modified hyaluronic acid is non-toxic; the cell survival rate in Comparative Example 3 is maintained above 90%, which is smaller than that in Examples 1-3 but still has a certain gap, indicating that the crude inner gel formed by the collision and aggregation of ε-polylysine hydrochloride and hyaluronic acid can protect cell survival to a certain extent.

[0091] 3. As shown in Table 3, the hyaluronic acid suture prepared by the present invention has good absorbability within 60 days.

[0092] 4. As can be seen from Table 4, the antibacterial properties of the hyaluronic acid sutures of Comparative Examples 1 and 2 are equivalent to those of the hyaluronic acid sutures of Examples 1-3; the antibacterial properties of the hyaluronic acid sutures of Comparative Example 3 are significantly different from those of the hyaluronic acid sutures of Examples 1-3, indicating that the inner gel crude product formed by the collision and aggregation of ε-polylysine hydrochloride and hyaluronic acid plays a major antibacterial role in the hyaluronic acid sutures of the present invention.

[0093] In the description of the specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0094] The above contents are merely examples and explanations of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the invention or exceed the scope defined by the claims, they shall all fall within the protection scope of the present invention.

Claims

1. A method for preparing a hyaluronic acid suture, characterized in that: The following steps are involved: S1. Dissolve hyaluronic acid in deionized water at 4°C, add N,N-dimethylformamide, adjust the pH of the reaction solution to 8-9 with 2% NaOH by mass, add methacrylic anhydride dropwise, maintain the pH value at 8-9 and stand for 12-14 hours, adjust the pH to 6-7 with 0.5% HCl at 25°C, add sodium periodate, stir in dark for 12-14 hours, dialyze with deionized water for 3 days, change the water 4 times a day, quickly freeze and lyophilize the purified solution to obtain modified hyaluronic acid; S2, stirring the modified hyaluronic acid in a water bath at 50-55° C. for 3-5 min, adding 1% by mass NaOH solution and 1,4-butanediol diglycidyl ether, stirring for 2-3 h, cooling to 25° C., and standing for 48 h to obtain a crude exogel; S3, dialyzing the crude outer gel, filtering through a polycarbonate membrane with decreasing pore size three times to obtain a spinning outer gel; S4, adding ε-polylysine hydrochloride to the sodium hyaluronate solution, ultrasonically homogenizing under heating conditions at 80° C. in a water bath for 30-60 minutes to obtain a crude inner gel; S5. The outer spinning gel and the inner spinning gel are loaded into different syringes respectively, and the inner and outer container ports of the coaxial nozzle are connected respectively. After setting the process parameters, spinning is started. After vacuum drying, the gel is refrigerated for later use, and the hyaluronic acid suture is obtained.

2. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The molecular weight of the hyaluronic acid described in S1 is 100-500 kDa.

3. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The dosage ratio of hyaluronic acid, deionized water, N,N-dimethylformamide, methacrylic anhydride and sodium periodate in S1 is 1g:50mL:50mL:(1.02-1.3)mL:0.53g.

4. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The usage ratio of modified hyaluronic acid, 1% NaOH solution and 1,4-butanediol diglycidyl ether in S2 is 25g:110g:(0.3-0.5)mg.

5. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The dialysis operation in S3 is as follows: 20 times of dialysis with normal saline, and finally 3 times of dialysis with 5% glucose normal saline buffer.

6. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The polycarbonate membranes with reduced pore size described in S3 are 2 μm membrane, 1.5 μm membrane and 1 μm membrane respectively.

7. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The final concentration of sodium hyaluronate in the crude inner gel of S4 is 50-80 mg / mL, and the final concentration of ε-polylysine hydrochloride is 500-650 mg / mL.

8. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The dosage ratio of the external spinning gel to the internal spinning gel in S5 is (1-1.08):

1.

9. The method for preparing a hyaluronic acid suture according to claim 1, characterized in that: The process parameters of S5 are: working voltage 15-25kV, the distance between the fixed needle collector and the high-speed orientation receiver is 15cm, the fixed speed of the high-speed orientation receiver is 200-300r / min, the flow rate is 1.94mL / h, and the spinning time is 8-20min.

10. A hyaluronic acid suture prepared by the preparation method according to any one of claims 1 to 9.